Beta-blockers and spironolactone in heart failure
- PMID: 10980877
- DOI: 10.1007/s11886-000-0003-8
Beta-blockers and spironolactone in heart failure
Abstract
Neurohormonal antagonism is now recognized as an essential treatment modality for heart failure. As a prime example, the benefits of blocking the renin-angiotensin system with angiotensin converting enzyme inhibitors are clearly established for all four New York Heart Association classes. In this clinical trials review, we discuss two other therapies with neurohormonal targets: beta-blockers and the sympathetic nervous system, and the aldosterone antagonist spironolactone.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials